Clinical course and outcome of COVID-19 in patients with rheumatic diseases: Are all biological disease-modifying antirheumatic drugs alike? Response to: Â € Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al
Articolo
Data di Pubblicazione:
2020
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
antirheumatic agents; biological therapy; rituximab
Elenco autori:
Monti, S.; Montecucco, C.
Link alla scheda completa:
Pubblicato in: